Search Within

Benjamin Heath Durham

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (27)
  2. Meeting Abstract (24)
  3. Correspondence (2)
  4. Research Letter (1)
Groups
  1. Department of Pathology and Laboratory Medicine (54)
  2. Center for Hematologic Malignancies (49)
  3. Department of Medicine (49)
  4. Hematologic Malignancies, Division of (49)
  5. GSK Faculty (45)
  6. Executive Committee, Center for Hematologic Malignancies (44)

More Groups

People
  1. Omar Abdel-Wahab (40)
  2. Eli Diamond (38)
  3. Ahmet Dogan (25)
  4. Kseniya Petrova-Drus (19)
  5. Raajit Rampal (17)
  6. Mariko Yabe (16)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (10)
  4. 2022 (4)
  5. 2020 (5)
  6. 2019 (6)

More Years

Publications
  1. Blood (16)
  2. Pediatric Blood and Cancer (7)
  3. Haematologica (3)
  4. British Journal of Haematology (2)
  5. Cancer Discovery (2)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (17)
  2. Nature Publishing Group (8)
  3. Wiley Periodicals, Inc (7)
  4. American Association for Cancer Research (3)
  5. Ferrata Storti Foundation (3)
  6. American Society of Clinical Oncology (2)

More Publishers

Results (54)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clonal characterization and somatic hypermutation assessment by next-generation sequencing in chronic lymphocytic leukemia/small lymphocytic lymphoma: A detailed description of the technical performance, clinical utility, and platform comparison
    Journal Article

    Petrova-Drus, K.; Syed, M.; Yu, W.; Hutt, K.; Zlotnicki, A. M.; Huang, Y.; Kamalska-Cyganik, M.; Maciag, L.; Wang, M.; Ma, Y. G.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Efficacy of alpelisib in PI3K-driven langerhans cell histiocytosis
    Meeting Abstract

    Mazor, R. D.; Durham, B. H.; Abdel-Wahab, O. I.; Diamond, E. L.; Yabe, M.; Itchaki, G.; Ben-Sasson, M.; Hershkovitz-Rokah, O.; Shpilberg, O.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • A multinational series of 26 patients with mixed histiocytic neoplasms highlighting a diverse mutational landscape and superior efficacy of targeted therapies
    Meeting Abstract

    Diamond, E. L.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Ulaner, G. A.; Reddy, R.; Lacouture, M. E.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • ALK-positive histiocytosis: A new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
    Journal Article

    Kemps, P. G.; Picarsic, J.; Durham, B. H.; Hélias-Rodzewicz, Z.; Hiemcke-Jiwa, L.; van den Bos, C.; van de Wetering, M. D.; van Noesel, C. J. M.; van Laar, J. A. M.; Verdijk, R. M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Yabe, M.; Petrova-Drus, K.; Rosenblum, M.; Rotemberg, V.; Lacouture, M. E.; Rampal, R.; Francis, J.; Knoerzer, D.; Kreider, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • First report of bilateral breast-implant associated anaplastic large cell lymphoma caused by identical T-cell clone
    Correspondence

    Stuver, R.; Lewis, N. E.; Ewalt, M. D.; Dogan, A.; Durham, B. H.; Plitas, G.; McCarthy, C.; Horwitz, S. M.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • ALK+ histiocytosis: A new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
    Meeting Abstract

    Kemps, P.; Picarsic, J.; Durham, B. H.; Hélias-Rodzewicz, Z.; Hiemcke-Jiwa, L.; van den Bos, C.; van de Wetering, M. D.; van Noesel, C. J. M.; Hogendoorn, P. C. W.; Woei-A-Jin, F. J. S.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • PRMT5 inhibition modulates E2F1 methylation and gene-regulatory networks leading to therapeutic efficacy in JAK2(V617F)-mutant MPN
    Journal Article

    Pastore, F.; Bhagwat, N.; Pastore, A.; Radzisheuskaya, A.; Karzai, A.; Krishnan, A.; Li, B.; Bowman, R. L.; Xiao, W.; Viny, A. D.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Neurologic and oncologic features of Erdheim-Chester disease: A 30-patient series
    Journal Article

    Bhatia, A.; Hatzoglou, V.; Ulaner, G.; Rampal, R.; Hyman, D. M.; Abdel-Wahab, O.; Durham, B. H.; Dogan, A.; Ozkaya, N.; Yabe, M.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save